These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36052104)

  • 1. Transient Pneumonitis as a Possible Adverse Reaction to the BNT162b2 COVID-19 mRNA Vaccine in a Patient with Rheumatoid Arthritis: A Case Report and Review of the Literature.
    Ohkubo Y; Ohmura SI; Ishihara R; Miyamoto T
    Case Rep Rheumatol; 2022; 2022():3124887. PubMed ID: 36052104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible case of polyarteritis nodosa with epididymitis following COVID-19 vaccination: A case report and review of the literature.
    Ohkubo Y; Ohmura SI; Ishihara R; Miyamoto T
    Mod Rheumatol Case Rep; 2023 Jan; 7(1):172-176. PubMed ID: 36305628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New-onset Seropositive Rheumatoid Arthritis Following COVID-19 Vaccination in a Patient with Seronegative Status.
    Yonezawa H; Ohmura SI; Ohkubo Y; Miyamoto T
    Intern Med; 2022 Nov; 61(22):3449-3452. PubMed ID: 36070943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case Series on the COVID-19 Vaccines and Possible Immune-Related Adverse Events: A New Challenge for the Rheumatologists.
    Nahra V; Makandura M; Anthony DD; Mattar M
    Cureus; 2022 Sep; 14(9):e29660. PubMed ID: 36321010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracerebral hemorrhage due to vasculitis following COVID-19 vaccination: a case report.
    Takeyama R; Fukuda K; Kouzaki Y; Koga T; Hayashi S; Ohtani H; Inoue T
    Acta Neurochir (Wien); 2022 Feb; 164(2):543-547. PubMed ID: 34783899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Bartels LE; Ammitzbøll C; Andersen JB; Vils SR; Mistegaard CE; Johannsen AD; Hermansen MF; Thomsen MK; Erikstrup C; Hauge EM; Troldborg A
    Rheumatol Int; 2021 Nov; 41(11):1925-1931. PubMed ID: 34476603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 vaccination-related small vessel vasculitis with multiorgan involvement.
    Kim Y; Kang J; Lee SG; Kim GT
    Z Rheumatol; 2022 Aug; 81(6):509-512. PubMed ID: 35587834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse reactions to BNT162b2 mRNA COVID-19 vaccine in medical staff with a history of allergy.
    Inoue S; Igarashi A; Morikane K; Hachiya O; Watanabe M; Kakehata S; Sato S; Ueno Y
    Respir Investig; 2022 Mar; 60(2):248-255. PubMed ID: 34920980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Response in Regard to Hypersensitivity Reactions after COVID-19 Vaccination.
    Hsieh MH; Yamaguchi Y
    Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35884946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are the Allergic Reactions of COVID-19 Vaccines Caused by mRNA Constructs or Nanocarriers? Immunological Insights.
    Selvaraj G; Kaliamurthi S; Peslherbe GH; Wei DQ
    Interdiscip Sci; 2021 Jun; 13(2):344-347. PubMed ID: 34021862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aseptic Meningitis Following Second Dose of an mRNA Coronavirus Disease 2019 Vaccine in a Healthy Male: Case Report and Literature Review.
    Kang HS; Kim JE; Yoo JR; Oh H; Kim M; Kim YR; Heo ST
    Infect Chemother; 2022 Mar; 54(1):189-194. PubMed ID: 35132836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.
    Massari M; Spila Alegiani S; Morciano C; Spuri M; Marchione P; Felicetti P; Belleudi V; Poggi FR; Lazzeretti M; Ercolanoni M; Clagnan E; Bovo E; Trifirò G; Moretti U; Monaco G; Leoni O; Da Cas R; Petronzelli F; Tartaglia L; Mores N; Zanoni G; Rossi P; Samez S; Zappetti C; Marra AR; Menniti Ippolito F;
    PLoS Med; 2022 Jul; 19(7):e1004056. PubMed ID: 35900992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination.
    Nishiguchi Y; Matsuyama H; Maeda K; Shindo A; Tomimoto H
    BMC Neurol; 2021 Nov; 21(1):452. PubMed ID: 34789193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susac syndrome following COVID-19 vaccination: a case-based review.
    Fisher L; David P; Sobeh T; Liberman RB; Amital H
    Clin Rheumatol; 2023 Jun; 42(6):1713-1717. PubMed ID: 36877303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New-onset autoimmune phenomena post-COVID-19 vaccination.
    Chen Y; Xu Z; Wang P; Li XM; Shuai ZW; Ye DQ; Pan HF
    Immunology; 2022 Apr; 165(4):386-401. PubMed ID: 34957554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pfizer/BioNtech BNT162b2: adverse events and insights from an Australian mass vaccination clinic for COVID-19.
    Halder A; Imamura H; Condon S; Boroughs K; Nilsson SC; Anderson T; Caterson ID
    Intern Med J; 2022 Jan; 52(1):121-124. PubMed ID: 35060290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case Series and Literature Review of the Association of COVID-19 Vaccination With Autoimmune Diseases: Causality or Chance?
    Al-Allaf AW; Neethu M; Al-Allaf Y
    Cureus; 2022 Sep; 14(9):e28677. PubMed ID: 36199642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 mRNA vaccine-related interstitial lung disease: Two case reports and literature review.
    So C; Izumi S; Ishida A; Hirakawa R; Kusaba Y; Hashimoto M; Ishii S; Miyazaki H; Iikura M; Hojo M
    Respirol Case Rep; 2022 Apr; 10(4):e0938. PubMed ID: 35355663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of thrombocytopenic purpura following BNT162b2 mRNA COVID-19 vaccination].
    Shibata K; Tanaka H; Otani A; Kubo M; Hasegawa A; Amano I
    Rinsho Ketsueki; 2021; 62(10):1519-1521. PubMed ID: 34732627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Neurological Adverse Events Reported in VigiBase From COVID-19 Vaccines.
    Dutta S; Kaur R; Charan J; Bhardwaj P; Ambwani SR; Babu S; Goyal JP; Haque M
    Cureus; 2022 Jan; 14(1):e21376. PubMed ID: 35198288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.